BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22046815)

  • 1. [Interactions between oral anticoagulants and other medication in emergency department--a pharmacoepidemiologic approach].
    Apostoae F; Tarţău L; Lupuşoru CE
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):954-60. PubMed ID: 22046815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacoepidemiologic investigations about the interactions between oral anticoagulants and other drugs in patients with hemostasis disorders].
    Apostoae F; Tarţău L; Cimpoeşu D; Lupuşoru CE
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1155-61. PubMed ID: 22276463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors influencing activity of oral anticoagulants. Interactions with drugs and food].
    Sawicka-Powierza J; Rogowska-Szadkowska D; Ołtarzewska AM; Chlabicz S
    Pol Merkur Lekarski; 2008 May; 24(143):458-62. PubMed ID: 18634396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
    Pengo V; Cucchini U; Denas G; Davidson BL; Marzot F; Jose SP; Iliceto S
    Thromb Haemost; 2010 Feb; 103(2):442-9. PubMed ID: 20076843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
    Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
    Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulant therapy for heart disease: results in actual cardiology practice.
    Baggio D; Madore F; Lalonde G
    Can J Cardiol; 2000 Feb; 16(2):153-61. PubMed ID: 10694585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U; Lindbäck J; Wallentin L;
    Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulant therapy. Fundamentals, clinical practice and recommendations.
    Lemos Silva R; Carvalho de Sousa J; Calisto C; Braz Nogueira JM; Ravara L
    Rev Port Cardiol; 2007; 26(7-8):769-88. PubMed ID: 17939586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for valvular heart disease in community-based practice.
    Rose AJ; Ozonoff A; Henault LE; Hylek EM
    Thromb Haemost; 2010 Feb; 103(2):329-37. PubMed ID: 20024499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term follow-up in patients receiving anticoagulation therapy: potency of therapy and complications].
    Katsuki T; Saito M; Noda T; Yaginuma T; Hosoda S
    J Cardiol; 1994; 24(3):203-9. PubMed ID: 8207635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation.
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Ibáñez CL; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
    Am J Cardiol; 2011 May; 107(10):1489-93. PubMed ID: 21420049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V; Legnani C; Noventa F; Palareti G;
    Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.